This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

SAVE UP TO £400 IF YOU BOOK BY:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Ulrike Philippar, PhD
Senior Director Oncology, Global Head of Discovery Hematological Malignancies at Janssen R&D

Profile

PhD in Cellular Biology at the University of Tuebingen, Germany; Postdoctoral Fellow at MIT Cancer Center, Cambridge, USA; 6 years in Oncology R&D at Merck & Co., Boston, USA; since 8 years at Janssen Oncology R&D, Beerse, Belgium; current position: Senior Director Oncology, Global Head of Discovery Hematological Malignancies

Agenda Sessions

  • T-Cell redirecting Antibodies for the Treatment of Hematological Malignancies

    On Demand